Evidence map›Paper›PMID 32873405›Full record

ArticleVaccine2020

Cost estimates of diarrhea hospitalizations among children <5 years old in Zimbabwe.

Hilda A Mujuru, Eleanor Burnett, Kusum J Nathoo, Ismail Ticklay, Nhamo A Gonah, Arnold Mukaratirwa, Chipo Berejena, Portia Manangazira, Maxwell Rupfutse, Tyler Chavers and 4 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Hilda A MujuruHarare Central Hospital, Harare, Zimbabwe; Department of Paediatrics and Child Health, University of Zimbabwe, Zimbabwe. Electronic address: hmujuru@mweb.co.zw.
Eleanor BurnettDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Kusum J NathooHarare Central Hospital, Harare, Zimbabwe; Department of Paediatrics and Child Health, University of Zimbabwe, Zimbabwe.
Ismail TicklayDepartment of Paediatrics and Child Health, University of Zimbabwe, Zimbabwe; Parirenyatwa Group Hospitals, Harare, Zimbabwe.
Nhamo A GonahChitungwiza Central Hospital, Chitungwiza, Zimbabwe.
Arnold MukaratirwaNational Virology Laboratory, Harare, Zimbabwe.
Chipo BerejenaNational Virology Laboratory, Harare, Zimbabwe.
Portia ManangaziraEpidemiology and Disease Control, Ministry of Health and Child Care, Harare, Zimbabwe.
Maxwell RupfutseWorld Health Organization Country Office, Harare, Zimbabwe.
Tyler ChaversDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Goitom G WeldegebrielWorld Health Organization, Intercountry Support Team, Harare, Zimbabwe.
Jason M MwendaWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Umesh D ParasharDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Jacqueline E TateDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Centers for Disease Control and Prevention · USUniversity of Zimbabwe · ZWNational Blood Service Zimbabwe · ZWWorld Health Organization - Zimbabwe · ZWChitungwiza Municipality · ZWMinistry of Health and Child Welfare · ZWWorld Health Organization Regional Office for Africa · CG

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

introductionDiarrhoea is a leading killer of children <5 years old, accounting for 480,000 deaths in 2017. Zimbabwe introduced Rotarix into its vaccination program in 2014. In this evaluation, we estimate direct medical, direct non-medical, and indirect costs attributable to a diarrhea hospitalization in Zimbabwe after rotavirus vaccine introduction.

methodsChildren <5 years old admitted to Harare Central Hospital from June 2018 to April 2019 with acute watery diarrhea were eligible for this evaluation. A 3-part structured questionnaire was used to collect data by interview from the child's family and by review of the medical record. A stool specimen was also collected and tested for rotavirus. Direct medical costs were the sum of medications, consumables, diagnostic tests, and service delivery costs. Direct non-medical costs were the sum of transportation, meals and lodging for caregivers. Indirect costs are the lost income for household members.

resultsA total of 202 children were enrolled with a median age of 12 months (IQR: 7-21) and 48 (24%) had malnutrition. Children were sick for a median of 2 days and most had received outpatient medical care prior to admission. The median monthly household income was higher for well-nourished children compared to malnourished children (p < 0.001). The median total cost of a diarrhea illness resulting in hospitalization was $293.74 (IQR: 188.42, 427.89). Direct medical costs, with a median of $251.74 (IQR: 155.42, 390.96), comprised the majority of the total cost. Among children who tested positive for rotavirus, the median total illness cost was $243.78 (IQR: 160.92, 323.84). The median direct medical costs were higher for malnourished than well-nourished children (p < 0.001).

conclusionDirect medical costs are the primary determinant of diarrhea illness costs in Zimbabwe. The descriptive findings from this evaluation are an important first step in calculating the cost effectiveness of rotavirus vaccine.

Indexed as

RotavirusRotavirus InfectionsRotavirus VaccinesChildChild, PreschoolCost of IllnessDiarrheaHospitalizationHumansInfantZimbabweRotavirus VaccinesCostDiarrheaEconomic burdenRotavirusZimbabwe

Identifiers

PMID32873405
PMCPMC8082468
OpenAlexW3082766311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.